Cytomedix CT-112 is a drug candidate in early development. CT-112 represents a therapeutic intervention that addresses inflammatory mediated disease. Cytomedix currently is preparing IND submissions to be filed in early 2009.



More on CT-112 in the Technology section

© 2009 Cytomedix.  All Rights Reserved. Site Map | Terms & Conditions